Application
Enilconazole may be used as a reference compound to analyze the effect of enilconazole during the surgical treatment of canine nasal aspergillosis by rhinotomy combined with enilconazole infusion and oral itraconazole.
Caution
Please find SDS provided by EDQM here..
General description
Enilconazole is a topically active imidazole derivative, for veterinary application in poultry against Aspergillus sp., and in dogs, cattle, and horses for the treatment of dermatophytosis.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 60 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
This product has met the following criteria to qualify for the following awards: